Last updated: July 29, 2024
Sponsor: Aristotle University Of Thessaloniki
Overall Status: Active - Recruiting
Phase
N/A
Condition
Diabetes Mellitus, Type 1
Diabetic Neuropathy
Diabetes Mellitus Types I And Ii
Treatment
Blood sampling
Clinical Study ID
NCT04257877
1.109/21.11.2018
Ages 5-10 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Children with confirmed DT1 under insulin substitution therapy
Age 5-10 years
Good glycemic control with HbA1c ≤ 7.0%
Prepubertal patients
Absence of other diseases
Signed informed consent of the parents or guardians of patients
Exclusion
Exclusion Criteria:
Presence of organic cause for neuropathy
Presence of other chronic disease
Poor glycemic control
Medication
Study Design
Total Participants: 50
Treatment Group(s): 1
Primary Treatment: Blood sampling
Phase:
Study Start date:
November 20, 2018
Estimated Completion Date:
January 20, 2025
Connect with a study center
Unit of Pediatric Endocrinology, Diabetes and Metabolism-2nd Department of Pediatrics, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki
Thessaloniki, 54621
GreeceActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.